Articles tagged with Stem Cell Research
Researchers found that both skeletal muscle MSCs and adipose tissue MSCs improved left ventricle function and reduced infarct size after injection into the heart of laboratory rats. The study suggests that these cells may be a potential treatment modality for patients with acute myocardial infarction.
Scientists at Johns Hopkins Medicine have successfully used human stem cells to test how diseased cells respond to drugs, paving the way for faster and cheaper drug development. The study identified a promising compound for treating Riley-Day syndrome and demonstrated the potential for tailored treatments for individual patients.
Scientists from the Danish Stem Cell Center found that stem cells grow better in three-dimensional environments, leading to improved insulin-producing cell development. This discovery holds promise for improving diabetes treatment with cell therapy.
Scientists at Stanford Medicine have found a way to let the body direct differentiation of transplanted stem cells without forced manipulation. This breakthrough could speed FDA approval and enable new therapies using pluripotent stem cells.
Researchers at Yale University have discovered that genetic variations are common in the body's tissues, with 30% of skin cells harboring copy number variations. This finding has significant implications for genetic screening and our understanding of human development and disease.
Researchers have developed a safe co-culture system using human umbilical cord blood cells to support the expansion of human embryonic stem cells. This method eliminates the risk of tumor formation associated with traditional feeder cultures, making it a more feasible option for cell transplantation.
A recent study published in the British medical journal 'Clinical & Experimental Allergy' found that children with skin manifestations have increased levels of eosinophil progenitors in their blood. Exposure to environmental contaminants, such as cigarette smoke, was also linked to higher levels of allergy-relevant stem cells.
Researchers investigated the use of stem cells in treating equine tendon injuries. Bone marrow-derived mesenchymal stem cells and adipose-derived stem cells showed promise in strengthening tendons after injury, while umbilical cord blood-derived stem cells may offer even greater potential for tendon regeneration.
Researchers successfully grew and sorted induced pluripotent stem cells for use in cartilage repair and studying osteoarthritis. The breakthrough uses adult stem cells converted into embryonic-like stem cells to produce cartilage tissue.
A team of scientists has discovered a critical protein, Utf1, that balances activation and deactivation of genes for cell differentiation. This finding sheds light on the complex process of embryonic stem cell self-renewal and differentiation.
The partnership enables the publication of high-quality stem cell research in an open-access venue, promoting outreach and quality in the field. Stem Cell Reports will feature various article types and allow authors to retain full copyright over their work.
Researchers at OHSU have successfully demonstrated a new gene therapy method that can replace mutated mitochondrial DNA with healthy copies in human cells. This breakthrough has the potential to prevent devastating diseases passed from mother to infant.
A recent study by Duke University researchers has identified pleiotrophin as a protein that can promote the growth of blood stem cells. The finding may lead to new treatments for patients undergoing chemotherapy or bone marrow transplants, enabling them to quickly regenerate healthy blood levels.
Salk scientists pinpointed damage to neural stem cells, specifically deformed nuclear envelopes, leading to neuronal loss and dysfunction in Parkinson's patients. The discovery may lead to new diagnostic and therapeutic approaches, including targeted gene-editing technologies.
Scientists have identified a new type of stem cell that can generate new blood vessels, offering new possibilities for treating cardiovascular disease and cancer. The discovery could lead to the development of new therapeutics to prevent or stimulate neoangiogenesis.
Scientists at UC Santa Barbara aim to create a synthetic patch of fresh cells to replace malfunctioning ones in the eyes, treating age-related macular degeneration. The Garland Initiative, funded by philanthropist Bill Bowes, will advance regenerative bioengineering and cellular therapies for diabetic retinopathy.
Researchers at UCLA's Broad Center of Regenerative Medicine have discovered that the Trop2 protein promotes the self-renewal of cancer cells through a mechanism involving cleavage. This finding may lead to the development of new therapies that block Trop2 molecular signaling, stopping tumor growth in various epithelial malignancies.
Scientists at the University of Maryland School of Medicine created a stem cell model for Gaucher disease, allowing them to test potential therapies in a dish. The study uses genetically similar stem cells that react to drugs like patient cells, accelerating drug discovery and bringing hope to patients.
Researchers at Wake Forest Baptist Medical Center have isolated neural precursor cells from skeletal muscle tissue, which can survive in the brain and migrate to areas where neural stem cells originate. The cells also showed no signs of tumor formation, offering a potential alternative source for treating brain tumors and other central...
A Phase II intra-arterial stem cell trial has demonstrated the safety of a regenerative therapy in patients with ischemic stroke. The ALD-401 therapy uses patient-derived bone marrow stem cells to promote brain repair after stroke.
The New York Stem Cell Foundation has announced funding of $9 million to six new investigators conducting innovative stem cell and neuroscience research. The award will support these researchers as they establish their own laboratories and expand their work.
A Phase I clinical trial demonstrates signs of engraftment and safety at 1 year, with modest gains in neurological function. The study provides encouraging results for the use of transplanted neural stem cells as a potential treatment for severe myelination diseases.
Researchers identified epigenetic changes that occur in adult stem cells to generate different body tissues. The study shows that laboratory-created muscle and bone cells resemble those found in nature and are biologically secure for implantation.
A new regulator for heart formation has been discovered by studying DNA packaging in embryonic stem cells. The researchers found that specific genetic regulators are activated at distinct times during the process of transforming stem cells into heart muscle cells, revealing potential insights into human development and organ repair.
Researchers found that a developmental protein called fibroblast growth factor-2 drives aging muscle stem cells out of dormancy, reducing their ability to regenerate. Blocking FGF signaling improved muscle tissue repair in aged animals.
Researchers identify FGF2 as a protein that stimulates cells to divide and activates dormant stem cells, leading to muscle depletion. By administering an FGF2 inhibitor, they halted the decline in muscle stem cells in mice.
Researchers at Sanford-Burnham Medical Research Institute have developed a new method to generate induced pluripotent stem cells (iPSCs) by adding kinase inhibitors, which significantly increase cellular reprogramming efficiency. This breakthrough has the potential to accelerate disease research and drug development.
Researchers used magnetic particles to target transplanted stem cells to specific retinal locations, improving biochemical changes in the target tissue. Magnetic targeting also enhanced cell retention in a rat model of ischemia/reperfusion injury by over five-fold.
The Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research at Albert Einstein College of Medicine hosted its first stem cell institute symposium, showcasing the latest research on induced pluripotent stem cells and hematopoietic stem cells. The event featured four presentations by renowned speakers fr...
Researchers have successfully developed a stable population of neural crest cells from mice that can differentiate into multiple cell types. This breakthrough enables the study of stem cell biology and human development, as well as potential applications in understanding diseases.
Researchers at Hospital for Special Surgery are studying the use of platelet-rich plasma (PRP) and stem cells to treat tendon injury and degeneration. The goal is to develop an effective therapeutic strategy to improve healing and reduce complications in NFL players.
Researchers designed molecular beacons that bind to mRNA of three genes expressed only when stem cells transform into bone cells, allowing for real-time monitoring of gene expression. The technology provides a tool for discovering optimal conditions for stem cell differentiation and identifying desired tissue cells.
Researchers at the University of Maryland School of Medicine have found that cardiac stem cells from newborns have a three-fold ability to restore heart function compared to adult-derived cells. This discovery may lead to new treatment options for congenital heart syndrome and improve heart function in children by up to 15 percent.
Six UC San Diego researchers received over $7 million in CIRM funding to study human embryonic stem cells, induced pluripotent stem cells, and hematopoietic stem cells. Their work aims to develop unlimited sources of transplantable beta-cells for diabetes patients and promote immunological tolerance to hESC-derived tissues.
The California Institute for Regenerative Medicine awards UC Irvine $5.6 million for Alzheimer's research, while Dr. Henry Klassen receives $17.3 million to develop stem cells for retinitis pigmentosa treatment. Researchers aim to advance human clinical trials using stem cells to improve memory in people with Alzheimer's disease.
The Gruber Foundation honored Mary Gehring and Valerie Horsley with the Rosalind Franklin Young Investigator Award for their groundbreaking research in Arabidopsis epigenetics and mouse genetic models. The awards recognize early career female scientists making significant contributions to genetics.
Researchers discovered that tumor suppressor genes TSC and PTEN regulate stem cell-like blood precursor cells in fruit flies. The TOR pathway uses these genes to gauge nutrition levels and stress, expanding or increasing the number of blood progenitor cells. High levels of ROS were found to be valuable in this context.
A*STAR scientists have identified a potential drug target, miR-138, that can prevent the progression and relapse of glioblastoma multiforme, a deadly form of brain tumour. Depleting this biomarker with antimiR-138 led to complete destruction of cancer cells in vitro.
Researchers identified a unique cell type that bridges bone marrow stem cells and the entire human immune system, offering insights into healthy immune function and potential therapies for diseases. The study's findings have significant implications for understanding cancer development and treatment.
Weill Cornell Medical College has received $1.8 million in grants to support translational research for blood cancers, focusing on leukemia, AML, multiple myeloma, and long-term therapy effects. Researchers will investigate novel therapies and genomic diversity to develop targeted treatments.
New research reveals that fat-derived stem cells secrete VEGF and other factors that inhibit cartilage regeneration. Pre-treating the cells with antibodies against VEGF can neutralize these effects, promoting chondrocyte survival and cartilage repair.
Researchers at Michigan Medicine have discovered the crucial role of Mof in preserving stem cells' ability to become any type of cell. By regulating DNA access, Mof enables stem cells to maintain their 'stem-ness' and differentiate into specialized cells.
A new technique using amniotic fluid stem cells can regenerate damaged urethral sphincter muscles and prevent pressure incontinence in mice. Researchers found that the stem cells induced regeneration of the mouse's own urethral sphincter muscle with proper nerve connections.
Researchers have successfully derived human embryonic stem cells from frozen embryos after 18 years of storage. This breakthrough provides a valuable alternative source of ES cells for drug screening and medical research.
Researchers at Duke University Health System have found that mesenchymal stem cells can prevent post-traumatic arthritis in mice with fractures. The study suggests that these stem cells alter the balance of inflammation and regeneration in knee joints, thereby preventing the development of osteoarthritis.
Scientists have identified a new stem cell population that gives rise to neurons in the upper layers of the cerebral cortex, which are responsible for higher thinking. This finding paves the way for developing better treatments for cognitive disorders such as schizophrenia and autism by producing these neurons in culture.
A team of researchers at Mount Sinai School of Medicine found that Aurora A (Aurka) activates p53 by phosphorylation, promoting ESC self-renewal. The study provides insight into the role of Aurka in embryonic stem cell regulation and cancer development.
Researchers at Sanford-Burnham Medical Research Institute have discovered a molecule that converts stem cells into heart cells, potentially replacing diseased or damaged tissue in heart disease patients. The molecule, ITD-1, blocks TGFϐ signaling, allowing stem cells to differentiate into cardiomyocytes.
Researchers have discovered that embryonic endothelial precursors can differentiate into beating cardiomyocytes in the absence of Scl, a master regulator of blood development. This finding may provide new avenues for creating cardiac stem cells and treating heart conditions through regenerative medicine.
The California Institute for Regenerative Medicine has awarded $20 million to UCI and StemCells Inc. to advance joint project treating cervical spinal cord injury using human neural stem cells. The funding will support the collection of data necessary to establish human clinical trials in the US.
Researchers from IMIM have deciphered the role of β-catenin in generating haematopoietic stem cells, which can be used to treat leukaemia patients without compatible donors. The study lays the foundation for laboratory-generated stem cells that can improve transplant quality and quantity.
Researchers have successfully grown healthy small-diameter blood vessels using adult stem cells extracted during liposuction. These lab-grown vessels may replace the need for grafts from elsewhere in the body or artificial blood vessels, reducing risks of clotting and rejection.
Modified human stem cells helped enhance the activity of an enzyme called telomerase, which elongates telomere length. This technique increased telomere length and activity, as well as increasing cardiac stem cell proliferation, vital steps in combating heart failure.
A new study published in the journal Stem Cell reveals an antibody developed by researchers can detect stem cells in organs like the liver and pancreas. This breakthrough helps understand tissue regeneration and cancer diagnosis and treatment.
Researchers have discovered that cells from burn eschar can differentiate into multipotent mesenchymal stromal cells, which could be used to treat burn injuries. The study found that these cells had a resemblance to adipose-derived stem cells and may play a crucial role in wound healing.
Researchers at Albert Einstein College of Medicine found that abnormal bone marrow stem cells drive the development of myelodysplastic syndromes (MDS), serious blood diseases. The study reveals genetic and epigenetic alterations in stem and progenitor cells, offering new hope for targeted therapies and improved cure rates.
Cedars-Sinai researchers created a laboratory model for Huntington's disease using induced pluripotent stem cells from patients' skin cells. The 'disease in a dish' model allows scientists to test therapies directly on human Huntington's neurons, offering a new pathway to identifying treatments.
A team of scientists has generated a human model of Huntington's disease directly from the skin cells of affected patients, providing a new tool for researchers to study the disease and test potential therapies. The re-created neurons will help understand what disables and kills brain cells in people with HD.
Scientists successfully converted skin cells from a patient with severe Huntington's disease into neurons that degenerate like those affected by the fatal disorder. This breakthrough enables researchers to test potential drug therapies on human brain cells in a dish.
Researchers at UBC successfully reversed diabetes in mice using stem cells, restoring insulin production and reversing the disease. The study re-created the 'feedback loop' that enables insulin levels to automatically rise or fall based on blood glucose levels.